Marilyn F. Kraus, M.D. has been the principal investigator or investigator on several studies of interventions and/or outcomes in traumatic brain injury, which were funded and completed. She is currently still an investigator or consultant on three funded TBI studies. Her area of expertise both in research and clinically for over ten years is neuropharmacologic interventions in TBI and specifically the study of frontal lobe dysfunction after injury. She has multiple publications in the area of TBI.


Currently she is involved with the use of functional brain imaging (fMRI) to research the neurobehavioral effects (effects on cognition, mood, or behavior) of traumatic brain injury and potential pharmacologic treatments to improve function.